UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

An optimization model for the short-term manpower planning problem in transhipment container terminals

Computers & industrial engineering, 2016-07, Vol.97, p.183-190

2016

Volltextzugriff (PDF)

Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study

World journal of gastroenterology : WJG, 2016-12, Vol.22 (47), p.10432-10439

2016

Volltextzugriff (PDF)

Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia

Journal of clinical medicine, 2022-05, Vol.11 (10), p.2786

2022

Volltextzugriff (PDF)

Sa1900 BIOMARKERS RESPONSE TO ANTI-TNF TREATMENT IN CROHN'S DISEASE THROUGH THE INTESTINAL MICROBIOTA

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-471-S-471

2020

Volltextzugriff (PDF)

Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

Clinical gastroenterology and hepatology, 2024-05

2024

Volltextzugriff (PDF)

Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT Registry

Inflammatory bowel diseases, 2013-01, Vol.19 (1), p.73-80

2013

Volltextzugriff (PDF)

Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior?

Scandinavian journal of gastroenterology, 2018-09, Vol.53 (9), p.1079-1084

2018

Volltextzugriff (PDF)

Recomendaciones del Grupo Español de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) para el tratamiento de las fístulas perianales de la enfermedad de Crohn

Gastroenterología y hepatología, 2020-03, Vol.43 (3), p.155-168

2020

Volltextzugriff (PDF)

High Prevalence of Heartburn and Low Acid Sensitivity in Patients with Idiopathic Achalasia

Digestive diseases and sciences, 2011-03, Vol.56 (3), p.773-776

2011

Volltextzugriff (PDF)

Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry

Journal of Crohn's and colitis, 2024-04, Vol.18 (4), p.578-588

2024

Volltextzugriff (PDF)

Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease

Gastroenterología y hepatología, 2020-03, Vol.43 (3), p.155-168

2020

Volltextzugriff (PDF)

Real-world data on the infliximab biosimilar CT-P13 (Remsima ® ) in inflammatory bowel disease

World journal of clinical cases, 2021-12, Vol.9 (36), p.11285-11299

2021

Volltextzugriff (PDF)

Sa1170 Inflammatory Bowel Disease in the Late Elderly: Clinical Aspects, Immunosupression and Surgery

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-247-S-247

2015

Volltextzugriff (PDF)

Recommendations of the Crohn’s Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn’s disease

Gastroenterología y Hepatología (English Edition), 2020-03, Vol.43 (3), p.155-168

2020

Volltextzugriff (PDF)

Vedolizumab, una opción en pacientes con enfermedad inflamatoria intestinal intolerantes a tiopurinas y refractarios a biológicos

Gastroenterología y hepatología, 2018-11, Vol.41 (9), p.535-543

2018

Volltextzugriff (PDF)

Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease

Revista española de enfermedades digestivas, 2019-06, Vol.111 (6), p.431-436

2019

Volltextzugriff (PDF)

Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents

Gastroenterología y hepatología, 2018-11, Vol.41 (9), p.535-543

2018

Volltextzugriff (PDF)

Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents

Gastroenterología y Hepatología (English Edition), 2018-11, Vol.41 (9), p.535-543

2018

Volltextzugriff (PDF)

Certolizumab Pegol 200 mg Every Other Week for a Patient with Initial Long-Term Response to 400 mg Every 4 Weeks: Management of Loss of Response without Dose Increase

The American journal of gastroenterology, 2008-09, Vol.103, p.S427-S428

2008

Volltextzugriff (PDF)

A new guidewire cannulation technique in ERCP: successful deep biliary access with triple-lumen sphincterotome and guidewire controlled by the endoscopist

Surgical endoscopy, 2011-06, Vol.25 (6), p.1876-1882

2011

Volltextzugriff (PDF)

The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry

Journal of Crohn's and colitis, 2014-08, Vol.8 (8), p.763-769

2014

Volltextzugriff (PDF)

Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy

Gastroenterología y hepatología, 2019-06, Vol.42 (6), p.387-388

2019

Volltextzugriff (PDF)

Efficacy of Infliximab Rescue Therapy in Patients With Chronic Refractory Pouchitis: A Multicenter Study

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-591-S-591

2011

Volltextzugriff (PDF)

Paciente con enfermedad de Crohn en tratamiento con adalimumab y esteroides que desarrolla aspergilosis pulmonar

Gastroenterología y hepatología, 2019-06, Vol.42 (6), p.387-388

2019

Volltextzugriff (PDF)

Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy

Gastroenterología y Hepatología (English Edition), 2019-06, Vol.42 (6), p.387-388

2019

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(86)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(48)
Humans
(33)
Male
(23)
Female
(22)
Oncology
(18)
Middle Aged
(14)
Adult
(13)
Aged
(11)
Gastroenterology & Hepatology
(11)
Crohn's Disease
(8)
Medicine
(7)
Patients
(7)
Prostate Cancer
(7)
Ulcerative Colitis
(7)
Aged, 80 And Over
(6)
Biological And Medical Sciences
(6)
Biomarkers
(6)
Carcinoma, Renal Cell - Drug Therapy
(6)
Gastroenterology And Hepatology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

An optimization model for the short-term manpower planning problem in transhipment container terminals

Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study

Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia

Sa1900 BIOMARKERS RESPONSE TO ANTI-TNF TREATMENT IN CROHN'S DISEASE THROUGH THE INTESTINAL MICROBIOTA

Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT Registry

Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior?

Recomendaciones del Grupo Español de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) para el tratamiento de las fístulas perianales de la enfermedad de Crohn

High Prevalence of Heartburn and Low Acid Sensitivity in Patients with Idiopathic Achalasia

Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry

Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease

Real-world data on the infliximab biosimilar CT-P13 (Remsima ® ) in inflammatory bowel disease

Sa1170 Inflammatory Bowel Disease in the Late Elderly: Clinical Aspects, Immunosupression and Surgery

Recommendations of the Crohn’s Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn’s disease

Vedolizumab, una opción en pacientes con enfermedad inflamatoria intestinal intolerantes a tiopurinas y refractarios a biológicos

Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease

Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents

Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents

Certolizumab Pegol 200 mg Every Other Week for a Patient with Initial Long-Term Response to 400 mg Every 4 Weeks: Management of Loss of Response without Dose Increase

A new guidewire cannulation technique in ERCP: successful deep biliary access with triple-lumen sphincterotome and guidewire controlled by the endoscopist

The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry

Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy

Efficacy of Infliximab Rescue Therapy in Patients With Chronic Refractory Pouchitis: A Multicenter Study

Paciente con enfermedad de Crohn en tratamiento con adalimumab y esteroides que desarrolla aspergilosis pulmonar

Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy

Suchergebnisse filtern